Wang, Yen-Feng http://orcid.org/0000-0001-7027-3432
Wang, Shuu-Jiun
Funding for this research was provided by:
Taiwan Ministry of Science and Technology (MOST 109-2314-B-075 -054, MOST 108-2321-B-010-014 -MY2, 108-2321-B-010 001, and 108-2314-B-010-023-MY3)
Taipei Veterans General Hospital (VGH 108-C-092, VGH 109-C-096, VGH-109-D52-002-MY3-1, and VGH-109-D52-002-MY3-2)
Article History
Accepted: 7 June 2021
First Online: 16 July 2021
Declarations
:
: This review was sponsored in part by the Taiwan Ministry of Science and Technology [MOST 109-2314-B-075-054, MOST 108-2321-B-010-014-MY2, 108-2321-B-010 001, and 108-2314-B-010-023-MY3] and the Taipei Veterans General Hospital [VGH 108-C-092 and VGH 109-C-096, VGH-109-D52-002-MY3-1, and VGH-109-D52-002-MY3-2].YFW has received honoraria as a speaker from the Taiwan branches of Allergan/AbbVie, Eli Lilly, Novartis, Pfizer, Sanofi, and UCB. He has received research grants from the Taiwan Ministry of Science and Technology and the Taipei Veterans General Hospital. SJW has served on the advisory boards of Daiichi-Sankyo, Eli Lilly, and Novartis, has received honoraria as a moderator from Allergan/AbbVie, Pfizer, Eli Lilly, Biogen, and Eisai, and has been the PI in trials sponsored by Eli Lilly, Novartis, and Allergan/AbbVie. He has received research grants from the Taiwan Minister of Technology and Science (MOST), Brain Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan, Taipei Veterans General Hospital, Taiwan Headache Society, and Taiwan branches of Eli Lilly, Novartis, and Pfizer.
: This article does not contain any studies with human or animal subjects performed by any of the authors.